ClinicalTrials.govpublic full text
Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
alzheimer's disease, dementia, cognition, alpha-7 nachr, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 866554
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.